🇺🇸 FDA
Patent

US 11344605

Therapeutic use of inhibitors of t cell activation or stimulation

granted A61KA61K38/1709A61K38/1774

Quick answer

US patent 11344605 (Therapeutic use of inhibitors of t cell activation or stimulation) held by HUMANITAS MIRASOLE S.P.A. expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HUMANITAS MIRASOLE S.P.A.
Grant date
Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/1709, A61K38/1774, A61K39/001102, A61K48/00